Theranos still has yet to take advantage of the Cleveland Clinic's offer to test its blood diagnostic technology, says Dr. Toby Cosgrove.
As online viewers grow up, they're looking for digital shows that suit their needs. And this is also changing advertising as we know it.
Jim Cramer says the government has caused too much supply in the market, which will result in bad news for stocks with no end in sight.
The media wanted to believe in Theranos, but the blood-testing start-up has always been a "scam," Sam Waksal said.
Pharmacy reimbursement rates challenged Rite Aid earnings in the latest quarter, Chairman and CEO John Standley said, in a statement.
Take a look at some of Thursday's early movers: YHOO, M, RAD, CTRP, WMT, JBL
Jim Cramer deconstructs the core assets of Valeant, and found the most troubled part of a very troubled company.
Check out the companies making headlines after the bell Monday: Baidu, Square, Intuit and more.
LinkedIn, Apple, Yahoo and Walgreens are making headlines this Monday morning.
Take a look at some of Monday's early movers: AAPL, WBA, T, VZ, YHOO, VRX, SYMC
The drugstore chain will stop offering the blood-testing company's services at its stores.
Walgreens says it will close all 40 Theranos Wellness Centers and will no longer offer any Theranos services at any of its stores.
Shares of Walgreens and Rite Aid skyrocketed around 4 percent amid reports that the FTC is likely to approve Walgreens' acquisition of Rite Aid.
Ringing today's opening bell are US Foods Holding Corp CEO Pietro Satriano, at the NYSE; and Skip Bourdo, Corporate Operations Vice President of Walgreens, and Christy Gibb, Comic Relief Board of Trustees, at the Nasdaq.
Today's bell ringers are US Foods Holding Corp CEO Pietro Satriano, at the NYSE; and Skip Bourdo, Corporate Operations Vice President of Walgreens, and Christy Gibb, Comic Relief Board of Trustees, at the Nasdaq.
Adam Grant, Wharton professor of management, weighs in on Walgreens' deal with Theranos without first validating its technology.
Some of the names on the move ahead of the open.
Jim Cramer isn't loving this stock, but says the group is at least coming back and it's one of the best.
The pharmacy benefits manager is looking to partner with retail pharmacies that do the best job at keeping diabetes patients healthy.
Several recalls were announced this week, including Polaris ROVs and Nice! sliced peaches.